Premium
Infradiaphragmatic Hodgkin's disease, long term follow‐up of a rare presentation
Author(s) -
Liew K. H.,
Ding J. C.,
Cruickshank D.,
Quong G. G.,
Wolf M. M.,
Cooper I. A.
Publication year - 1991
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1991.tb02995.x
Subject(s) - medicine , splenectomy , stage (stratigraphy) , laparotomy , univariate analysis , disease , pathological , chemotherapy , b symptoms , proportional hazards model , surgery , radiation therapy , survival analysis , gastroenterology , multivariate analysis , spleen , paleontology , biology
Hodgkin's disease limited to the infradiaphragmatic region was seen in 30 of 306 (9.8%) of all Stage I and II patients referred to the Peter MacCallum Cancer Institute between 1968 and 1980. The male:female ratio was 2.3:1 with median age of 43.5 years at presentation. Of the seven patients with clinical stage (CS) IA‐IIA disease who had staging laparotomy and splenectomy only one CSIIA patient had splenic involvement. The patients were staged as pathological stage (PS) IA 2, PSIIA 5, CSIA 4, CSIIA 10, CSIIB 9. Primary treatment was by radiation in 24 patients, combination chemotherapy in five and surgical excision in one. Twenty‐five patients achieved complete response. Relapse free survival (RFS) at five and ten years was 59% and the five and ten‐year survival was 75% and 67% respectively. On univariate analysis the significant prognostic factors for RFS and survival were stage, constitutional symptoms and presence of bulky disease. Using Cox regression analysis the only significant variable for RFS and survival was bulky disease ( p = 0.01, 0.02). A treatment policy for patients with infradiaphragmatic Hodgkin's disease is recommended.